$33.38
Price
$3.8B
Market Cap
—
P/E Ratio
-9.0
Forward P/E
$-2.12
EPS (TTM)
—
Dividend Yield
$715M
Cash
$1M
Total Debt
113M
Shares Out
$18.92
$43.15
52-Week Range
Institutional Ownership of VIKING THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for VIKING THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2024-Q4 | |||||
| SELL | EXIT | — | — | $55.06 | |
| 2024-Q3 | |||||
| SELL | -46.7% | 721.9K | $46M | $58.10 | |
| 2024-Q2 | |||||
| BUY | +23.7% | 1.4M | $72M | $65.36 | |
| 2024-Q1 | |||||
| SELL | -78.7% | 1.1M | $90M | $31.85 | |
| 2023-Q4 | |||||
| BUY | +12.5% | 5.1M | $96M | $11.27 | |
| 2023-Q3 | |||||
| BUY | +29.0% | 4.6M | $51M | $14.44 | |
| 2023-Q2 | |||||
| BUY | +81.3% | 3.5M | $57M | $21.46 | |
| 2023-Q1 | |||||
| BUY | NEW | 2.0M | $33M | $9.96 | |
Insider Trading for VIKING THERAPEUTICS INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.